| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/06/2005 | CN1634409A Medicine capable of reducing blood fat and treating anaphylactic rhinitis and preparation method thereof |
| 07/06/2005 | CN1634398A Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension |
| 07/06/2005 | CN1634397A Special nutritious oral liquid with corn active small molecule |
| 07/06/2005 | CN1634354A Vegetable estrogen analogy composition capable of replacing estrogen and its application |
| 07/06/2005 | CN1634352A Compound diabetes-treating sugar-decreasing fat-reducing preparation and preparation method thereof |
| 07/06/2005 | CN1634351A Green papaya capsule and preparation method thereof |
| 07/06/2005 | CN1634328A Chinese traditional medicine composition for treating diabetic nephropathy |
| 07/06/2005 | CN1634325A Apocynum extract and extracting method thereof |
| 07/06/2005 | CN1634321A Chinese traditional medicine preparation for treating diabetic chronic retinopathy and preparation method thereof |
| 07/06/2005 | CN1634302A Medicine for treating gout, hyperuricemia and hyperlipemia and preparation method thereof |
| 07/06/2005 | CN1634279A Chinese traditional medicine for treating diabetes |
| 07/06/2005 | CN1634189A Infusion containing gen-seng, lilyturf root, Chinese magnoliavine fruit and amino acid and its production method |
| 07/06/2005 | CN1634188A Infusion of astragalus root and amino acid and its preparing method |
| 07/06/2005 | CN1634187A Infusion of gen-seng, lilyturf root and amino acid and its preparing method |
| 07/06/2005 | CN1634186A Compound red sage root and amino acid infusion and its preparing method |
| 07/06/2005 | CN1634174A Chinese traditional medicine for treating diabetes |
| 07/06/2005 | CN1634169A Moutan bark and leech containing capsule for lowering blood sugar and its preparation method |
| 07/06/2005 | CN1634166A Medicine for treating diabetes and its preparation method |
| 07/06/2005 | CN1634142A Preparing method of orally administered insulin or polypeptide protecting agent and usage thereof |
| 07/06/2005 | CN1634129A Sustained release high calcium formulation and preparation process thereof |
| 07/06/2005 | CN1634109A Prescription with fat metabolism regulating function and its preparing method |
| 07/06/2005 | CN1634106A Breviscapine oral rapidly disintegrating formulation and its preparing process |
| 07/06/2005 | CN1634104A Sustained release mini pills of breviscapine and its preparing process |
| 07/06/2005 | CN1634095A Gynostemme pentaphylium soft capsule and its preparing process |
| 07/06/2005 | CN1634069A Calcium, zinc and ferrum composite oral liquor and its preparing process |
| 07/06/2005 | CN1634030A Use of piperic acid ester compound in preparation of drug or healthcare product for reducing blood fat |
| 07/06/2005 | CN1634029A Use of pepper amide compound in preparation of drug or healthcare product for reducing blood fat |
| 07/06/2005 | CN1634013A Zinc gluconate oral disintegrating tablet and its preparation process |
| 07/06/2005 | CN1634010A Calcium gluconate oral disintegrating tablet and its preparation process |
| 07/06/2005 | CN1634008A Compound metformin hydrochloride xylitol oral preparation and its production method |
| 07/06/2005 | CN1634001A Alkannin nano-granule and its preparation method |
| 07/06/2005 | CN1633891A Compound nutrients of hydrolyzed yeast , pollen, complete animal and plant essential fatty acid and its preparation method |
| 07/06/2005 | CN1209362C Tetrazolyl-phenyl acetamide glucokinase activators |
| 07/06/2005 | CN1209361C Hydantoin-containing glucokinase activators |
| 07/06/2005 | CN1209359C Novel dihydric indole compound, their preparation process and medicinal compositions containing them |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209166C Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 07/06/2005 | CN1209155C Balsam pear products containing multiple hypoglycemic active composition and preparation thereof |
| 07/06/2005 | CN1209146C Fumigant for treating prosopalgia and its preparing process |
| 07/06/2005 | CN1209141C Chinese medicine preparation for weight-off and fat reduction |
| 07/06/2005 | CN1209132C Method for extracting medicine for hyperlipemia from Chinese onion bulb |
| 07/06/2005 | CN1209126C New use of ledebouriella root |
| 07/06/2005 | CN1209125C Diabetes treating medicine |
| 07/06/2005 | CN1209122C Chinese patent drug for treating diabetes |
| 07/06/2005 | CN1209109C Slow-releasing acipimox tablet |
| 07/06/2005 | CN1209103C Fenofibrate soft capsule and its preparation method |
| 07/06/2005 | CN1209101C Metformin hydrochloride sustained-release tablet and method for preparing the same |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | CA2360677C Anticonvulsant derivatives useful in treating bulimia nervosa |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2093946C Methanediphosphonic acid formulations with ion exchangers |
| 06/30/2005 | WO2005058858A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 06/30/2005 | WO2005058306A1 Glutamine-containing energy imparting amino acid composition or amino acid solution |
| 06/30/2005 | WO2005033099A3 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 06/30/2005 | WO2005026315A3 Method for producing insulin from a natural source and insulin |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004055005A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143467 Adjust fatty acid oxidation; stimulant carnitine palmitoly transferase |
| 06/30/2005 | US20050143464 With low side effects, which rapidly stimulate early insulin secretion and suppress blood glucose increase only at mealtimes; antidiabetic agent; triterpene acids or alcohols with picene ring; corosolic acids; oleanene acids; ursenoic acids; banaba plant extracts |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143440 Excellent hypoglycemic agents for treating hyperglycemia, dyslipidemia, hypercholesterolemia, noninsulin-dependent type II diabetes, obesity, glucose intolerance, cardiovascular diabetic complications; reduced side effects due to absence of serotonin reuptake inhibition; imidazoline receptor pathologies |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143377 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143354 Association of an antithrombotic and aspirin |
| 06/30/2005 | US20050143322 Method for treating obesity |
| 06/30/2005 | US20050143304 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 06/30/2005 | US20050142628 Use |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142604 Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2210 |
| 06/30/2005 | US20050142535 Ogligonucleotides comprising alternating segments and uses thereof |
| 06/30/2005 | US20050142191 Pharmaceutical formulations of amyloid inhibiting compounds |
| 06/30/2005 | US20050142167 Soluble highly branched glucose polymers and their method of production |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142123 Comprising droplets of Coenzyme Q-10 dispersed in a matrix of a modified polysaccharide or a gelatin; supplement for human and animal nutrition |
| 06/30/2005 | US20050142065 Administering test compound to a diabetes mellitus model non-human mammal such as a rat; selecting compound that causes a decrease in a glycated hemoglobin value after administration; drug screening |
| 06/30/2005 | US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction |
| 06/30/2005 | CA2550695A1 Glp-1 pharmaceutical compositions |
| 06/30/2005 | CA2550050A1 Novel glp-1 analogues linked to albumin-like agents |
| 06/30/2005 | CA2548790A1 Medicinal compositions and combinations |
| 06/30/2005 | CA2548285A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2005 | CA2547804A1 Novel thiazole derivatives |
| 06/30/2005 | CA2546793A1 Use of stating for the treatment of metabolic syndrome |
| 06/30/2005 | CA2545506A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 06/30/2005 | CA2543074A1 Novel 2-(piperazin-1-yl)- and 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |